tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment
PremiumCompany Announcements89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment
1M ago
89bio Elects Directors and Approves Proposals at Annual Meeting
Premium
Company Announcements
89bio Elects Directors and Approves Proposals at Annual Meeting
3M ago
89bio price target lowered to $30 from $31 at BofA
Premium
The Fly
89bio price target lowered to $30 from $31 at BofA
4M ago
89bio assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly89bio assumed with an Overweight at Cantor Fitzgerald
4M ago
89bio Updates on Pegozafermin Clinical Progress
Premium
Company Announcements
89bio Updates on Pegozafermin Clinical Progress
5M ago
89bio initiated with a Neutral at Goldman Sachs
Premium
The Fly
89bio initiated with a Neutral at Goldman Sachs
6M ago
89bio reports Q4 EPS ($1.02), consensus (76c)
PremiumThe Fly89bio reports Q4 EPS ($1.02), consensus (76c)
6M ago
ETNB Insider Trade Alert! Majority Shareholder Buys $50M Worth of 89bio Stock
Premium
Market News
ETNB Insider Trade Alert! Majority Shareholder Buys $50M Worth of 89bio Stock
7M ago
3 Best Stocks to Buy Now, 2/4/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 2/4/2025, According to Top Analysts
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100